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1. Introduction 
Netherton syndrome is an uncommon autosomal recessive disorder characterized by 
congenital ichthyosis with defective cornification, bamboo hair, and severe atopic 
manifestation. It is caused by mutations in SPINK5. Atopic dermatitis is shown to be 
associated with polymorphisms in SPINK5.  
In 1958, Netherton described the bamboo-like deformity in the fragile hairs in a girl with 
erythematous scaly dermatitis.[2] In 1985, Greene and Muller emphasized the triad of 
Netherton syndrome: ichthyosis, atopy, and trichorrhexis invaginata.[3] In 2000, Chavanas 
et al. identified eleven different mutations in SPINK5 in 13 families with Netherton 
syndrome.[4] Their finding disclosed a critical role of the serine protease inhibitor 
lymphoepithelial Kazal-type related inhibitor (LEKTI) in epidermal barrier function and 
immunity, suggesting a sequential pathway for high serum IgE levels and atopic 
manifestations.[4] In 2005, Descargues et al. found that LEKTI is a key regulator of 
epidermal protease activity and degradation of desmoglein 1 as the primary pathogenic 
event.[5] In 2010, Sales showed that a pathogenic matriptase-pro-kallikrein pathway could 
operate in a variety of physiological and pathological processes.[6] Thus, the study of 
Netherton syndrome contributes not only elucidation of pathogenesis of the disorder itself 
but also understanding of structure of the epidermis and immune and inflammatory 
processes including atopic dermatitis.  
In this session, we summarize (1) the clinical features of Netherton syndrome, (2) the genetic 
relationship of SPINK5 to atopic dermatitis, and (3) the molecular functions. 
2. The clinical features of Netherton syndrome 
Netherton syndrome is an uncommon autosomal recessive disease characterized by 
ichthyosis linearis circumflexa and/or congenital ichthyosiform erythroderma, hair shaft 
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defects including trichorrhexis invaginata, trichorrhexis nodosa and pili torti and atopic 
manifestations with an elevated IgE level, frequent asthma and food allergies.[1] It is caused 
by mutations in SPINK5 encoding LEKTI. 
The infants with Netherton syndrome commonly show a generalized erythroderma covered 
by fine, translucent scales, which can be difficult to distinguish clinically from 
erythrodermic psoriasis, non-bullous congenital ichthyosiform erythroderma, or other 
infantile erythrodermas.[7] Electron microscopy is useful for diagnosis. It illustrates 
premature lamellar body secretions and foci of electron-dense materials in the intercellular 
spaces of stratum corneum.[7] Patients with a mild phenotype of ichthyosis linearis 
circumflexa on the palms and soles will have mutations located downstream near the C-
terminal end, while a severe erythrodermic phenotype will be associated with nucleotide 
changes with early truncations in SPINK5.[8, 9]  
Trichorrhexis invaginata (bamboo hair) is a focal defect of the hair shaft that produces 
development of torsion nodules and invaginated nodules.[1] Invagination of affected hairs 
is caused by softness of the cortex in the keratogenous zone because of an incomplete 
formation of disulfide bonds.[10]  
Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases 
hyperactivity.[11] This skin barrier defect favors allergen absorption and is generally 
regarded as the underlying cause for atopic dermatitis-like lesions in Netherton 
syndrome.[11] Uncontrolled kallikreins (KLK)s activity in Netherton syndrome epidermis 
can trigger atopic dermatitis-like lesions, independently of the environment and the 
adaptive immune system.[11]  
3. The genetic relationship of SPINK5 to atopic dermatitis 
Atopic dermatitis is a chronic and relapsing inflammatory skin disorder caused by multiple 
genetic and environmental factors. A recent genome-wide association studies for atopic 
dermatitis identified susceptibility loci at 1q21.3 (FLG), 5q22.1 (TMEM232 and SLC25A46) 
and 20q13.33 (TNFRSF6B and ZGPAT) in the Chinese samples (4,636 cases and 13,559 
controls),[12] and a genome-wide association meta-analysis detected susceptibility loci at 
11q13.5 (OVOL1), 19p13.2 (ACTL9), and 5q22.1 (KIF3A) in 5,606 affected individuals and 
20,565 controls from 16 population-based cohorts and an additional 5,419 affected 
individuals and 19,833 controls from 14 studies.[13] Andiappan et al. showed no evidence of 
association of the locus at 5q22.1, even though the effect sizes in the Singaporean Chinese 
population are similar to that reported in Sun et al.[12, 14] These results indicate that atopic 
dermatitis is more multi-factors-involved and complicated disorder than vitiligo and 
alopecia areata.[15, 16]  
Association of SPINK5 gene polymorphisms with atopic dermatitis has been shown in case-
control studies,[17-20] even though genome-wide association studies for atopic dermatisis 
have not identified the statistic significance. It would be indispensable to accumulate 
patients with typical atopic dramatis, which should be classified into the extrinsic or 
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intrinsic types, and distinct healthy controls with no family and personal history of atopic 
dermatitis, allergic rhinitis and/or asthma for next investigation of genome-wide association 
studies for atopic dermatitis.  
Fortugno et al. investigated the functional difference between representative associated 
polymorphism, Glu420Lys, because glutamic acid (Glu E) is an acidic amino acid and lysine 
(Lys K) is a basic.[21] They showed increased epidermal protease activity correlates with 
reduced desmoglein 1 protein expression and accelerated profilaggrin proteolysis under the 
presence of residue 420K within the SPINK5 sequence, contributing to defective skin barrier 
permeability.[21] They found that epidermis with homozygous lysine residues in codon 420 
in SPINK5 displays an increased expression of the proallergic cytokine thymic stromal 
lymphopoietin (TSLP).[21] Further functional analysis would shed light on the involvement 
of the decreased activity of LEKTI in atopic dermatitis.  
4. The molecular functions 
The epidermis consists of the basal layer, the spinous layer, the granular layer and the 
cornified layer. The hair follicle is constructed by the inner root sheath, the outer root sheath 
and the hair bulb. LEKTI is expressed in the granular layer of the epidermis and in the inner 
root sheet of hair follicle and acts as an inhibitor of multiple serine proteases. [4] LEPTI 
contains fifteen serine protease inhibitor domains and its proteolytic fragments inhibit 
epidermal proteases. [22-28] LEPTI can inhibit the epidermal serine protease KLK5, KLK6, 
KLK7, KLK13 and KLK14. [29] LEKTI-domain 6 was shown to specifically inhibit KLK5 and 
KLK7 in the mid-to-high nanomolar range. [30] Thus, protease inhibitors such as LEPTI are 
crucial players for controlling protease activity.  
KLK5 can cleave desmoglein 1, inducing the detachment of stratum corneum and 
subsequent severe skin barrier defect which is associated with high permeability of various 
allergens. Unrepressed KLK5 activity can be present in loss-of-functional mutation in 
SPINK5 in Netherton syndrome and decreased functional polymorphisms in SPINK5 in 
atopic dermatitis. Unrestrained KLK5 activates an autonomous protease-activated-receptor-
2 (PAR2) signaling, resulting in the production of major-pro-inflammatory molecules and 
pro-T helper 2 cytokines such as TSLP.[31] The specific KLK5-PAR-2-TSLP pathway induces 
atopic dermatitis-like lesions in Netherton syndrome and atopic dermatitis in individuals 
with predisposed polymorphisms.     
KLK7 is involved in stratum corneum desquamation via the disruption of 
corneodesmosomes and the cell-cell adhesion junctions of corneocytes by hydrolyzing the 
two mayor cadherins (corneodesmosin and desmocollin 1) in the extracellular region of the 
junctions. [32]  
Matriptase is a transmembrane tripsin-like serine protease having the capacity of 
autoactivation and subsequent occurrence of proteolytic cascade reactions.[33, 34] Sales et al. 
showed that matriptase is an efficient activator of epidermal pro-KLKs that co-localize with 
LEKTI at the granular-transitional layer boundary where epidermal separation takes place 
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in Netherton syndrome.[6] They demonstrated that all the central manifestations of 
Netherton syndrome in LEKTI-deficient mice, such as aberrant proteolytic activity in the 
lower epidermis, corneodesmosome fragility, stratum corneum loss and skin inflammation, 
depend on the epidermal expression of matriptase.[6] Thus, pro-KLKs might be activated as 
KLKs which trigger excess proteolytic function under the functional loss of LEKTI in 
Netherton syndrome or functional insufficiency of LEKTI in atopic dermatitis with 
decreased functional polymorphisms in SPINK5.   
The functional loss or insufficiency of LEKTI induces relative excess activation of serine 
protease toward severe skin allergy. 
5. Conclusion 
Recently, studies for the interaction between proteases and protease inhibitors are focused 
on the elucidation of pathogenesis of Netherton syndrome, atopic dermatitis, asthma, and 
food allergies. Atopic manifestation with an elevated IgE level in Netherton syndrome 
prompted researches to investigate the genetic relationship between atopic dermatitis and 
genetic polymorphisms. LEKTI encoded by functionally decreased polymorphisms can alter 
proteolytic activation and protease deregulation. The relationship between atopic dermatitis 
and improper cornification has been focused not only in model mice of Netherton syndrome 
but also in flaky tail mice with double filaggrin and loricrin deficiencies.[35] Further study 
will discover more precise mechanism in cornification, which would provide novel 
strategies for effective treatment for Netherton syndrome and atopic dermatitis.  
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